抗菌药物管理项目对重症监护病房住院患者的影响:前瞻性审计与反馈研究
在巴勒斯坦医疗中心ICU开展前瞻性审计与反馈式抗菌药物管理项目(ASP),比较实施前后各4个月数据。ASP干预后抗菌药物使用量下降24.3%,疗程和住院时间中位数均显著缩短,30天死亡率和再入院率无显著差异。
要点
- ASP干预平均接受率78.4%,剂量优化接受率87.0%,基于培养结果的降阶梯接受率84.4%。
- ASP后抗菌药物使用量从87.3降至66.1 DDD/100床,降幅24.3%(P<0.001)。
- ASP后住院时间中位数从11天降至7天(P<0.01),疗程中位数从8天降至5天(P=0.01)。
核心结论
- 前瞻性审计与反馈式ASP对ICU抗菌药物使用、疗程和住院时间有积极影响。
- ASP干预未显著改变30天全因死亡率和再入院率。
研究设计与样本
- 在巴勒斯坦医疗中心ICU开展的前瞻性审计与反馈研究。
- ASP团队在抗菌药物给药后48-72小时内进行干预和反馈。
- 比较实施前4个月与实施后4个月的数据。
- 收集临床和人口学数据,以及抗菌药物使用量(以限定日剂量测量)、疗程、住院时间、再入院和全因死亡率。
主要发现
- ASP团队共进行176次干预,平均接受率78.4%。
- 剂量优化接受率87.0%,基于培养结果的降阶梯接受率84.4%。
- ASP干预显著降低抗菌药物使用量24.3%(87.3 DDD/100床 vs. 66.1 DDD/100床,P<0.001)。
- 住院时间中位数(四分位距)显著缩短[11(3-21)天 vs. 7(4-19)天,P<0.01]。
- 疗程中位数(四分位距)显著缩短[8(5-12)天 vs. 5(3-9)天,P=0.01]。
关键数值与推荐
- ASP干预平均接受率78.4%。
- 剂量优化接受率87.0%,基于培养结果的降阶梯接受率84.4%。
- 抗菌药物使用量降幅24.3%(P<0.001)。
- 住院时间中位数缩短4天(P<0.01),疗程中位数缩短3天(P=0.01)。
临床怎么用
- 在ICU对抗菌药物处方进行48-72小时内前瞻性审计与反馈,可减少抗菌药物使用量。
- 优先实施剂量优化和基于培养结果的降阶梯干预,接受率较高。
- ASP干预可缩短抗菌药物疗程和住院时间,且未增加30天死亡率或再入院率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Inappropriate use of antibiotics is one of the most important factors contributing to the emergence of drug resistant pathogens. The purpose of this study was to measure the clinical impact of antimicrobial stewardship programme (ASP) interventions on hospitalized patients at the Intensive care unit at Palestinian Medical Complex. METHODS: A prospective audit with intervention and feedback by ASP team within 48-72 h of antibiotic administration began in September 2015. Four months of pre-ASP data were compared with 4 months of post-ASP data. Data collected included clinical and demographic data; use of antimicrobials measured by defined daily doses, duration of therapy, length of stay, readmission and all-cause mortality. RESULTS: Overall, 176 interventions were made the ASP team with an average acceptance rate of 78.4%. The most accepted interventions were dose optimization (87.0%) followed by de-escalation based on culture results with an acceptance rate of 84.4%. ASP interventions significantly reduces antimicrobial use by 24.3% (87.3 defined daily doses/100 beds vs. 66.1 defined daily doses/100 beds P < 0.001). The median (interquartile range) of length of stay was significantly reduced post ASP [11 (3-21) vs. 7 (4-19) days; P < 0.01]. Also, the median (interquartile range) of duration of therapy was significantly reduced post-ASP [8 (5-12) days vs. 5 (3-9); P = 0.01]. There was no significant difference in overall 30-day mortality or readmission between the pre-ASP and post-ASP groups (26.9% vs. 23.9%; P = 0.1) and (26.1% vs. 24.6%; P = 0.54) respectively. CONCLUSIONS: Our prospective audit and feedback programme was associated with positive impact on antimicrobial use, duration of therapy and length of stay.
引用
- Khdour MR, Hallak HO, Aldeyab MA, et al. Impact of antimicrobial stewardship programme on hospitalized patients at the intensive care unit: a prospective audit and feedback study. Br J Clin Pharmacol. 2018. PMID: 29236303. doi:10.1111/bcp.13486
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。